Interwoven indigo tendrils descending through clear water

Why age-related diseases arrive together

Blood pressure that crept up in the fifties, a fasting glucose drifting a point a year, sleep that no longer restores, a waist that thickened without any change in behaviour. Four specialists, four diagnoses, and rarely one on its own.

Written by Dr Mitra Basu Chhillar, M.D. Published 26 August 2026 Updated 2 September 2026 Reviewed by Team SOMA 6 min read
Listen to this article

Read the problem list of almost anyone in their late sixties and the same cluster appears. Blood pressure that crept up in the fifties. A fasting glucose drifting a point a year. Sleep that no longer restores. A waist that thickened without any change in behaviour. Four specialists, four diagnoses. The strange part is how rarely one arrives alone.

Underneath that cluster sit four processes, with arrows running between them. By the end of this article you will be able to name the four and draw the arrows, because the arrows explain the cluster.

Which two of the four are signalling problems?

Acute inflammation is one of the better things the body does. A cut, a virus, a torn muscle: blood flow rises, immune cells arrive, damage is cleared, and a resolution phase shuts the programme down. It hurts, it works, it ends.

Chronic low-grade inflammation is not a louder version of that. It runs at a fraction of the intensity. It produces no heat or redness, and shows up only as modest rises in blood markers such as CRP. What it lacks is the ending. Chronic inflammation is the same repair programme running without its off switch: harm by duration, not intensity.

The second is insulin, and the common picture of it is wrong. It looks like a sugar problem. That is the readout, not the fault. Insulin is a message: fuel has arrived, take it in, stop releasing your own. Insulin resistance means the cell answers that message less. The pancreas compensates by raising its voice.

Insulin resistance is a signalling failure long before it is a glucose one. Insulin can run high for years while fasting glucose stays reassuringly normal. Glucose moves only when the compensation runs out, and that is late.

The remaining two are not about messages at all.

What are the other two processes about?

Power. Oxidants, reactive molecules made from oxygen, are not intruders. Cells make them constantly, use them as signals, and deploy them against microbes. A repair and antioxidant system keeps pace. Oxidative stress is not the presence of oxidants but a balance tipped: production running ahead of the systems that handle it. The surplus reacts with membranes, proteins and DNA.

Most of that production happens in mitochondria, the structures that turn fuel and oxygen into usable energy. How much they supply sets what a tissue can afford. That is why the organs with the highest demand, brain, heart and muscle, notice a shortfall first.

What makes mitochondria the hinge is this. They are the largest source of oxidants, and also the most exposed target, because their membranes and small genome sit beside the production line. A system that damages itself in proportion to how hard it works is already a circle rather than a line.

That circularity is the shape of all four together.

Which way do the arrows run?

Both ways. Start around the loop in one direction. Inflammatory messenger molecules interfere with the machinery just inside the insulin receptor, so an inflamed tissue is a partially deaf one. Poor glucose handling then delivers fuel faster than mitochondria can process it, and the overflow leaks into oxidant formation. That surplus wears mitochondrial membranes and their DNA. Failing mitochondria leak their contents, and because mitochondria are bacterial in ancestry, the immune system reads those fragments as infection. The circle closes back at inflammation.

Now run it the other way, because each arrow has a partner. High insulin and sugar-coated proteins push immune cells towards an inflammatory setting. Oxidative damage to signalling proteins blunts insulin’s message further. Struggling mitochondria make more oxidants per unit of fuel. Inflammatory signalling suppresses the building of new mitochondria. Every arrow has a partner running the opposite way, which makes this a loop rather than a chain.

Chronic inflammation Insulin resistance Oxidative load Mitochondrial output Visceral fat an endocrine tissue blunts insulin signalling fuels inflammation more oxidants harms signalling wears mitochondria leaks oxidants signals alarm dents output
Teal arrows run one way round the loop: inflammation blunts insulin signalling, poor glucose handling raises oxidant production, oxidants wear mitochondria, failing mitochondria leak fragments read as alarm. Ink arrows are the same couplings running the other way. Visceral fat sits at the centre, feeding two nodes and expanded by them.

How much of this does a standard blood panel show? About one and a half of the four. Glucose and HbA1c report the insulin arrow’s consequences. CRP gives a crude view of inflammation. The other two are largely invisible in routine testing, so most of the loop is deduced rather than measured. Only one part is visible from the outside.

Why does visceral fat sit at the junction?

Fat packed around the abdominal organs behaves nothing like fat under the skin. Doctors call it visceral fat. As that depot expands, it recruits immune cells and shifts towards inflammatory output. It releases fatty acids straight into the blood supply serving the liver, and it secretes signalling molecules of its own. Visceral fat is a hormone-producing tissue that happens to store fat, which is why it sits in the middle of the diagram.

It drives inflammation and blunts insulin signalling. Insulin resistance, in turn, favours storage in that very depot. The waistline is not only a marker of the loop but one of its working parts. And the loop explains three things that look like coincidence.

Why do single-number wins so often disappoint?

The first thing the loop explains is clustering. Raised blood pressure, drifting glucose, fat in the liver and a thickening waist keep company because they share upstream causes. They are outputs of one system, not four diseases with a taste for the same people.

The second is inertia. Push one node while every arrow feeding it stays intact, and the loop restores it. The number moves, the system does not. That is the familiar experience of a marker improving while nothing feels different.

The third follows from the second. A change that touches three arrows gently tends to move the system further than one aimed hard at a single number. Sleep improves inflammatory tone and next-day insulin sensitivity together. Strength work gives muscle a way of taking up glucose that does not need insulin, and it is among the strongest builders of new mitochondria. Eating pattern, what and when, changes glucose swings and the oxidative load that follows. None of these is aimed at one node, and that is the point.

One honest qualification. The loop organises real biology, and each arrow rests on experimental work. But the whole framework is a model, not a proven unified theory of ageing. Other processes matter too, cellular senescence and protein quality control among them, and which node leads differs between people.

Clinical pearl

When one marker improves and nothing else does, that is information about the loop rather than proof of progress. The useful question about any change is not which number it moves, but how many of the four arrows it touches.

What to hold on to

  • Chronic inflammation is the repair programme without its ending: harm by duration, not intensity.
  • Insulin resistance is a signalling failure years before glucose reports it.
  • Oxidative stress is a balance tipped. Mitochondria are both main source and main target.
  • The four couple in both directions, so they cluster in one person and resist being shifted alone.
  • Visceral fat is an active hormone-producing tissue at the junction of several arrows.

Once the arrows are visible, findings in this field stop being separate facts and become positions on one diagram. The Longevity knowledge check will show whether they have settled in.

Dr Mitra Basu Chhillar, M.D. Dr Mitra Basu Chhillar, M.D. Founder and Medical Director, SOMA Longevity Sciences. Over thirty years of clinical practice in preventive, functional and regenerative medicine.

This article leads somewhere

Scroll to Top